Literature DB >> 12851493

FHA domain-mediated DNA checkpoint regulation of Rad53.

Marc F Schwartz1, Soo-Jung Lee, Jimmy K Duong, Seda Eminaga, David F Stern.   

Abstract

Saccharomyces cerevisiae Rad53 is a protein kinase central to the DNA damage and DNA replication checkpoint signaling pathways. In addition to its catalytic domain, Rad53 contains two forkhead homology-associated (FHA) domains (FHA1 and FHA2), which are phosphopeptide binding domains. The Rad53 FHA domains are proposed to mediate the interaction of Rad53 with both upstream and downstream branches of the DNA checkpoint signaling pathways. Here we show that concurrent mutation of Rad53 FHA1 and FHA2 causes DNA checkpoint defects approaching that of inactivation or loss of RAD53 itself. Both FHA1 and FHA2 are required for the robust activation of Rad53 by the RAD9-dependent DNA damage checkpoint pathway, while an intact FHA1 or FHA2 allows the activation of Rad53 in response to replication block. Mutation of Rad53 FHA1 causes the persistent activation of the RAD9-dependent DNA damage checkpoint pathway in response to replicational stress, suggesting that the RAD53-dependent stabilization of stalled replication forks functions through FHA1. Rad53 FHA1 is also required for the phosphorylation-dependent association of Rad53 with the chromatin assembly factor Asf1, although Asf1 itself is apparently not required for the prevention of DNA damage in response to replication block.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12851493

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  28 in total

1.  A Ddc2-Rad53 fusion protein can bypass the requirements for RAD9 and MRC1 in Rad53 activation.

Authors:  Soo-Jung Lee; Jimmy K Duong; David F Stern
Journal:  Mol Biol Cell       Date:  2004-09-29       Impact factor: 4.138

Review 2.  The histone chaperone Asf1 at the crossroads of chromatin and DNA checkpoint pathways.

Authors:  Florence Mousson; Françoise Ochsenbein; Carl Mann
Journal:  Chromosoma       Date:  2006-12-19       Impact factor: 4.316

3.  Mechanisms of checkpoint kinase Rad53 inactivation after a double-strand break in Saccharomyces cerevisiae.

Authors:  Ghislaine Guillemain; Emilie Ma; Sarah Mauger; Simona Miron; Robert Thai; Raphaël Guérois; Françoise Ochsenbein; Marie-Claude Marsolier-Kergoat
Journal:  Mol Cell Biol       Date:  2007-02-26       Impact factor: 4.272

Review 4.  Chromatin disassembly and reassembly during DNA repair.

Authors:  Jeffrey G Linger; Jessica K Tyler
Journal:  Mutat Res       Date:  2007-01-21       Impact factor: 2.433

5.  Mechanistically distinct roles for Sgs1p in checkpoint activation and replication fork maintenance.

Authors:  Lotte Bjergbaek; Jennifer A Cobb; Monica Tsai-Pflugfelder; Susan M Gasser
Journal:  EMBO J       Date:  2004-12-23       Impact factor: 11.598

6.  Genetic interaction of RAD53 protein kinase with histones is important for DNA replication.

Authors:  Teresa M Holzen; Robert Sclafani
Journal:  Cell Cycle       Date:  2010-12-01       Impact factor: 4.534

7.  Novel role for checkpoint Rad53 protein kinase in the initiation of chromosomal DNA replication in Saccharomyces cerevisiae.

Authors:  Paul R Dohrmann; Robert A Sclafani
Journal:  Genetics       Date:  2006-07-02       Impact factor: 4.562

8.  Acetylated lysine 56 on histone H3 drives chromatin assembly after repair and signals for the completion of repair.

Authors:  Chin-Chuan Chen; Joshua J Carson; Jason Feser; Beth Tamburini; Susan Zabaronick; Jeffrey Linger; Jessica K Tyler
Journal:  Cell       Date:  2008-07-25       Impact factor: 41.582

9.  CDC5 inhibits the hyperphosphorylation of the checkpoint kinase Rad53, leading to checkpoint adaptation.

Authors:  Genevieve M Vidanes; Frédéric D Sweeney; Sarah Galicia; Stephanie Cheung; John P Doyle; Daniel Durocher; David P Toczyski
Journal:  PLoS Biol       Date:  2010-01-26       Impact factor: 8.029

10.  Rad53 phosphorylation site clusters are important for Rad53 regulation and signaling.

Authors:  Soo-Jung Lee; Marc F Schwartz; Jimmy K Duong; David F Stern
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.